Abstract:Objective To investigate the effect of Ganlu Qingwen Formula (GLQWF) on the Bcl-2/Bax/Caspase-3 signaling pathway and its role in inhibiting apoptosis in a rat model of lipopolysaccharide (LPS)-induced acute lung injury (ALI)/acute respiratory distress syndrome (ARDS).Methods Forty-eight male SD rats were randomized into: Blank (saline), Model (LPS), Dexamethasone (Dex, 2 mg/kg), and GLQWF Low, Medium, High dose groups (0.6, 1.2, 2.4 g/kg). Drugs were administered by gavage for 3 days. On day 3, ALI was induced by intratracheal LPS instillation (Blank: saline). Lung histopathology (H&E), serum and lung tissue cytokines (ELISA: TNF-α, IFN-γ, IL-6), and lung tissue apoptosis-related protein (Western blot) and mRNA (qRT-PCR) expression (Bcl-2, Bax, Caspase-3) were analyzed.Results Model group lungs showed extensive consolidation and inflammation. GLQWF (all doses) and Dex significantly reduced serum and lung TNF-α, IFN-γ, IL-6 levels compared to Model (P < 0.05). GLQWF (Medium/High doses) and Dex significantly increased Bcl-2 protein/mRNA and decreased Bax/Caspase-3 protein/mRNA expression compared to Model (P < 0.05). High-dose GLQWF showed greater effects on protein expression than low-dose.Conclusion Ganlu Qingwen Formula alleviates LPS-induced ALI/ARDS by modulating the Bcl-2/Bax/Caspase-3 pathway, promoting anti-apoptotic Bcl-2 expression, and inhibiting pro-apoptotic Bax and Caspase-3 expression.